Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. 29 de jun. de 2024 · Haloperidol Esteve se utiliza en pacientes adultos para tratar enfermedades que afectan al modo de pensar, sentir o comportarse. Entre ellas están los problemas de salud mental (como la esquizofrenia y el trastorno bipolar) y los problemas de conducta.

  2. Hace 4 días · Haloperidol may result in an increase in the incidence of leaving the study early due to adverse effects compared to olanzapine (RR 1.99, 95% CI 1.60 to 2.47; 21 studies, 5047 participants; low-certainty evidence). For every 22 people treated with haloperidol instead of olanzapine, one fewer person would experience this outcome. ...

  3. www.vidal.fr › medicaments › gammesHALDOL - VIDAL

    Hace 4 días · Il est utilisé dans le traitement : de certains troubles psychiques ( schizophrénie, certains types de psychoses, troubles graves du comportement chez l'enfant...), de certaines manifestations d'anxiété (à faible posologie ), de certains mouvements anormaux, des vomissements dus aux chimiothérapies anticancéreuses.

  4. Hace 4 días · The evidence suggests that haloperidol may result in a large increase in extrapyramidal side effects compared to olanzapine (RR 3.38, 95% CI 2.28 to 5.02; 14 studies, 3290 participants; low-certainty evidence). For every three people treated with haloperidol instead of olanzapine, one additional person would experience extrapyramidal side effects.

  5. 26 de jun. de 2024 · A review of studies comparing haloperidol to second-generation antipsychotics found that nearly all trials used haloperidol doses that were near, or exceeded, the recommended upper limit. This suggests that some of the claims of superior efficacy and tolerability for second-generation antipsychotics based on these trials may be overstated.

  6. Haloperidol is a great dopamine stand-in, binding dopamine receptors even more tightly than dopamine itself. This binding, however, doesn’t kick-off the same response as ...

  7. Hace 2 días · The largest percentage took flupentixol (35.6%), followed by risperidone (27.8%) and haloperidol (23.4%). Investigators found no significant difference between first- and second-generation LAIs in ...

  1. Otras búsquedas realizadas